Phagocytic clearance of apoptotic cells: role in lung disease

References

• Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle6(6), 686–695 (2007).
   PubMed Web of Science ®Google Scholar
• Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am. J. Physiol. Lung Cell. Mol. Physiol.294(4), L601–L611 (2008).
   PubMedGoogle Scholar
• Maderna P, Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim. Biophys. Acta1639(3), 141–151 (2003).
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest129(6), 1673–1682 (2006).
   PubMed Web of Science ®Google Scholar
• Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol.7(12), 964–974 (2007).
   PubMed Web of Science ®Google Scholar
• Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med.182(5), 1597–1601 (1995).
   PubMed Web of Science ®Google Scholar
• Williamson P, Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim. Biophys. Acta1585(2–3), 53–63 (2002).
   PubMedGoogle Scholar
• Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med.203(12), 2613–2625 (2006).
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Ogden CA, Fadok VA et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol.169(7), 3978–3986 (2002).
   PubMed Web of Science ®Google Scholar
• Gardai SJ, McPhillips KA, Frasch SC et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell123(2), 321–334 (2005).
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Sastry K, Bailly P, Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med.172(6), 1785–1794 (1990).
   PubMed Web of Science ®Google Scholar
• Weihua Z, Tsan R, Schroit AJ, Fidler IJ. Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling. Cancer Res.65(24), 11529–11535 (2005).
   PubMed Web of Science ®Google Scholar
• Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature450(7168), 435–439 (2007).
   PubMed Web of Science ®Google Scholar
• Park D, Tosello-Trampont AC, Elliott MR et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature450(7168), 430–434 (2007).
   PubMed Web of Science ®Google Scholar
• Park SY, Jung MY, Kim HJ et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ.15(1), 192–201 (2007).
   Google Scholar
• Park SY, Kim SY, Jung MY, Bae DJ, Kim IS. EGF-like domain repeat (EGFrp) of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol. Cell. Biol.28(17), 5288–5298 (2008).
   PubMedGoogle Scholar
• Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature405(6782), 85–90 (2000).
   PubMed Web of Science ®Google Scholar
• Bose J, Gruber A, Helming L et al. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J. Biol.3(4), 15 (2004).
   PubMedGoogle Scholar
• Schlegel RA, Williamson P. PS to PS (phosphatidylserine) – pertinent proteins in apoptotic cell clearance. Sci. STKE (408), E57 (2007).
   Google Scholar
• Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest.90(4), 1513–1522 (1992).
   PubMed Web of Science ®Google Scholar
• Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature417(6885), 182–187 (2002).
   PubMed Web of Science ®Google Scholar
• Ishimoto Y, Ohashi K, Mizuno K, Nakano T. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J. Biochem.127(3), 411–417 (2000).
   PubMed Web of Science ®Google Scholar
• Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature392(6675), 505–509 (1998).
   PubMed Web of Science ®Google Scholar
• Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl Acad. Sci. USA93(22), 12456–12460 (1996).
   PubMed Web of Science ®Google Scholar
• Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl Acad. Sci. USA92(21), 9580–9584 (1995).
   PubMedGoogle Scholar
• Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med.194(6), 781–795 (2001).
   PubMed Web of Science ®Google Scholar
• Takemura Y, Ouchi N, Shibata R et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest.117(2), 375–386 (2007).
   PubMed Web of Science ®Google Scholar
• Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature418(6894), 200–203 (2002).
   PubMed Web of Science ®Google Scholar
• Tsai RK, Discher DE. Inhibition of ‘self’ engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J. Cell Biol.180(5), 989–1003 (2008).
   PubMed Web of Science ®Google Scholar
• Krieser RJ, White K. Engulfment mechanism of apoptotic cells. Curr. Opin. Cell Biol.14(6), 734–738 (2002).
   Google Scholar
• Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell81(1), 53–62 (1995).
   PubMed Web of Science ®Google Scholar
• Leverrier Y, Ridley AJ. Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages. Curr. Biol.11(3), 195–199 (2001).
   Google Scholar
• Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J. Biol. Chem.278(50), 49911–49919 (2003).
   Google Scholar
• Morimoto K, Janssen WJ, Fessler MB et al. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J. Immunol.176(12), 7657–7665 (2006).
   PubMed Web of Science ®Google Scholar
• Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest.109(1), 41–50 (2002).
   PubMed Web of Science ®Google Scholar
• Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature390(6658), 350–351 (1997).
   PubMed Web of Science ®Google Scholar
• Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med.188(5), 887–896 (1998).
   PubMed Web of Science ®Google Scholar
• Chen W, Frank ME, Jin W, Wahl SM. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity14(6), 715–725 (2001).
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest.101(4), 890–898 (1998).
   PubMed Web of Science ®Google Scholar
• Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity21(5), 643–653 (2004).
   PubMedGoogle Scholar
• Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity21(5), 643–653 (2004).
   PubMedGoogle Scholar
• Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol.172(2), 880–889 (2004).
   PubMed Web of Science ®Google Scholar
• Lucas M, Stuart LM, Zhang A et al. Requirements for apoptotic cell contact in regulation of macrophage responses. J. Immunol.177(6), 4047–4054 (2006).
   PubMed Web of Science ®Google Scholar
• Dini L, Lentini A, Diez GD et al. Phagocytosis of apoptotic bodies by liver endothelial cells. J. Cell Sci.108(Pt 3), 967–973 (1995).
   PubMed Web of Science ®Google Scholar
• Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J. Immunol.153(7), 3218–3227 (1994).
   PubMed Web of Science ®Google Scholar
• Kolb S, Vranckx R, Huisse MG, Michel JB, Meilhac O. The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells. J. Pathol212(3), 249–259 (2007).
   Google Scholar
• Walsh GM, Sexton DW, Blaylock MG, Convery CM. Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. Blood94(8), 2827–2835 (1999).
   PubMed Web of Science ®Google Scholar
• Monks J, Rosner D, Jon Geske F et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ.12(2), 107–114 (2005).
   PubMed Web of Science ®Google Scholar
• Golpon HA, Fadok VA, Taraseviciene-Stewart L et al. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J.18(14), 1716–1718 (2004).
   PubMed Web of Science ®Google Scholar
• Morimoto K, Amano H, Sonoda F et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am. J. Respir. Cell Mol. Biol.24(5), 608–615 (2001).
   PubMed Web of Science ®Google Scholar
• Michlewska S, McColl A, Rossi AG, Megson IL, Dransfield I. Clearance of dying cells and autoimmunity. Autoimmunity40(4), 267–273 (2007).
   PubMed Web of Science ®Google Scholar
• Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum.48(10), 2888–2897 (2003).
   PubMed Web of Science ®Google Scholar
• O’Brien BA, Fieldus WE, Field CJ, Finegood DT. Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats. Cell Death Differ.9(4), 457–464 (2002).
   PubMedGoogle Scholar
• Botto M, Dell’Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet.19(1), 56–59 (1998).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med.163(3 Pt 1), 737–744 (2001).
   PubMed Web of Science ®Google Scholar
• Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am. J. Respir. Cell Mol. Biol.28(5), 551–554 (2003).
   PubMed Web of Science ®Google Scholar
• Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir. Res.7, 53 (2006).
   PubMed Web of Science ®Google Scholar
• Tang K, Rossiter HB, Wagner PD, Breen EC. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J. Appl. Physiol.97(4), 1559–1566 (2004).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest.106(11), 1311–1319 (2000).
   PubMed Web of Science ®Google Scholar
• Tuder RM, Zhen L, Cho CY et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol.29(1), 88–97 (2003).
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol.28(5), 555–562 (2003).
   PubMed Web of Science ®Google Scholar
• Zheng T, Kang MJ, Crothers K et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-γ-induced alveolar remodeling and pulmonary emphysema. J. Immunol.174(12), 8106–8115 (2005).
   PubMed Web of Science ®Google Scholar
• Petrache I, Natarajan V, Zhen L et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med.11(5), 491–498 (2005).
   PubMed Web of Science ®Google Scholar
• Calabrese F, Giacometti C, Beghe B et al. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir. Res.6(1), 14 (2005).
   PubMed Web of Science ®Google Scholar
• Imai K, Mercer BA, Schulman LL, Sonett JR, D’Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur. Respir. J.25(2), 250–258 (2005).
   PubMed Web of Science ®Google Scholar
• Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest125(2), 626–632 (2004).
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol.81(4), 289–296 (2003).
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol.37(6), 748–755 (2007).
   PubMed Web of Science ®Google Scholar
• Richens TR, Linderman DJ, Xiao YQ et al. Cigarette smoke impairs removal of apoptotic cells (efferocytosis) through oxidant-dependent activation of RhoA. Presented at: American Thoracic Society Internation Conference. Toronto, Canada, 16–21 May 2008.
   Google Scholar
• Sims M, Tal-Singer R, Kierstein S et al. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir. Res.9(1), 13 (2008).
   PubMed Web of Science ®Google Scholar
• Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KBM. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J. Immunol.169(6), 2892–2899 (2002).
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Fadok VA, Ogden CA et al. Impaired clearance of apoptotic cells from cystic fibrosis airways. Chest121(3 Suppl.), S89 (2002).
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Fadok VA, Hoffmann PR et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest.109(5), 661–670 (2002).
   PubMed Web of Science ®Google Scholar
• Gοmez MI, Prince A. Opportunistic infections in lung disease: pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol.7(3), 244–251 (2007).
   PubMedGoogle Scholar
• Allen L, Dockrell DH, Pattery T et al. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J. Immunol.174(6), 3643–3649 (2005).
   PubMed Web of Science ®Google Scholar
• Bianchi SM, Prince LR, McPhillips K et al. Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med.177(1), 35–43 (2008).
   PubMed Web of Science ®Google Scholar
• Ras GJ, Anderson R, Taylor GW et al. Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro. J. Infect. Dis.162(1), 178–185 (1990).
   PubMed Web of Science ®Google Scholar
• Hogan SP, Rosenberg HF, Moqbel R et al. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy38(5), 709–750 (2008).
   PubMed Web of Science ®Google Scholar
• Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med.154(1), 237–243 (1996).
   PubMed Web of Science ®Google Scholar
• Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J. Allergy Clin. Immunol.106(1 Pt 1), 77–83 (2000).
   PubMed Web of Science ®Google Scholar
• Tai PC, Sun L, Spry CJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol.85(2), 312–316 (1991).
   PubMed Web of Science ®Google Scholar
• Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J. Immunol.145(9), 2950–2958 (1990).
   PubMed Web of Science ®Google Scholar
• Huynh ML, Malcolm KC, Kotaru C et al. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am. J. Respir. Crit. Care Med.172(8), 972–979 (2005).
   PubMedGoogle Scholar
• Takai D, Nagase T, Shimizu T. New therapeutic key for cystic fibrosis: a role for lipoxins. Nat. Immunol.5(4), 357–358 (2004).
   Google Scholar
• Kollef MH, Schuster DP. The acute respiratory distress syndrome. N. Engl. J. Med.332(1), 27–37 (1995).
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Steinberg KP et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol.163(4), 2217–2225 (1999).
   PubMed Web of Science ®Google Scholar
• Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am. J. Physiol. Lung Cell. Mol. Physiol.294(4), L632–L641 (2008).
   PubMed Web of Science ®Google Scholar
• Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med.160(5 Pt 2), S5–S11 (1999).
   PubMed Web of Science ®Google Scholar
• Lesur O, Kokis A, Hermans C, Fulop T, Bernard A, Lane D. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit. Care Med.28(12), 3814–3822 (2000).
   Google Scholar
• Fowler AA, Hyers TM, Fisher BJ et al. The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk. Am. Rev. Respir. Dis.136(5), 1225–1231 (1987).
   PubMed Web of Science ®Google Scholar
• Teder P, Vandivier RW, Jiang D et al. Resolution of lung inflammation by CD44. Science296(5565), 155–158 (2002).
   PubMed Web of Science ®Google Scholar
• Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol.159, 919–925 (1997).
   PubMed Web of Science ®Google Scholar
• McKee CM, Penno MB, Cowman M et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest.98(10), 2403–2413 (1996).
   PubMed Web of Science ®Google Scholar
• Hussain N, Wu F, Zhu L, Thrall RS, Kresch MJ. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am. J. Respir. Cell Mol. Biol.19, 867–874 (1998).
   PubMedGoogle Scholar
• Wang L, Medan D, Mercer R et al. Role of neutrophil apoptosis in vanadium-induced pulmonary inflammation in mice. J. Environ. Pathol. Toxicol. Oncol.21(4), 343–350 (2002).
   PubMedGoogle Scholar
• Cox G, Crossley J, Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell Mol. Biol.12(2), 232–237 (1995).
   PubMed Web of Science ®Google Scholar
• Medan D, Wang L, Yang X, Dokka S, Castranova V, Rojanasakul Y. Induction of neutrophil apoptosis and secondary necrosis during endotoxin-induced pulmonary inflammation in mice. J. Cell Physiol.191(3), 320–326 (2002).
   Google Scholar
• Joseph B, Lewensohn R, Zhivotovsky B. Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann. NY Acad. Sci.926, 204–216 (2000).
   Google Scholar
• Nachmias B, Ashhab Y, Ben Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin. Cancer Biol.14(4), 231–243 (2004).
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J. Cell. Biochem.88(5), 885–898 (2003).
   PubMed Web of Science ®Google Scholar
• Krysko DV, Vandenabeele P. From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ.15(1), 29–38 (2008).
   PubMed Web of Science ®Google Scholar
• Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med.191(3), 423–434 (2000).
   PubMed Web of Science ®Google Scholar
• Bondanza A, Zimmermann VS, Rovere-Querini P et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med.200(9), 1157–1165 (2004).
   PubMed Web of Science ®Google Scholar
• Popovic ZV, Sandhoff R, Sijmonsma TP et al. Sulfated glycosphingolipid as mediator of phagocytosis: sm4s enhances apoptotic cell clearance and modulates macrophage activity. J. Immunol.179(10), 6770–6782 (2007).
   Google Scholar
• Morichika H, Hamanaka Y, Tai T, Ishizuka I. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer78(1), 43–47 (1996).
   Google Scholar
• Ward C, Dransfield I, Chilvers ER, Haslett C, Rossi AG. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci.20(12), 503–509 (1999).
   PubMed Web of Science ®Google Scholar
• Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med.181(5), 1857–1862 (1995).
   PubMed Web of Science ®Google Scholar
• Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol.156(11), 4422–4428 (1996).
   PubMed Web of Science ®Google Scholar
• Liu Y, Cousin JM, Hughes J et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol.162(6), 3639–3646 (1999).
   PubMedGoogle Scholar
• Giles KM, Ross K, Rossi AG, Hotchin NA, Haslett C, Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol.167(2), 976–986 (2001).
   PubMedGoogle Scholar
• Brady HR, Serhan CN. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity. Curr. Opin. Nephrol. Hypertens.5(1), 20–27 (1996).
   Google Scholar
• Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. (Lond.)77(2), 195–203 (1989).
   PubMed Web of Science ®Google Scholar
• Soyombo O, Spur BW, Lee TH. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy49(4), 230–234 (1994).
   PubMed Web of Science ®Google Scholar
• Levy BD, De Sanctis GT, Devchand PR et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med.8(9), 1018–1023 (2002).
   PubMed Web of Science ®Google Scholar
• Karp CL, Flick LM, Park KW et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol.5(4), 388–392 (2004).
   PubMed Web of Science ®Google Scholar
• Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol.164(4), 1663–1667 (2000).
   PubMed Web of Science ®Google Scholar
• Mitchell S, Thomas G, Harvey K et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol.13(10), 2497–2507 (2002).
   PubMed Web of Science ®Google Scholar
• Maderna P, Cottell DC, Berlasconi G, Petasis NA, Brady HR, Godson C. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of Rho GTPases. Am. J. Pathol.160(6), 2275–2283 (2002).
   Google Scholar
• Reville K, Crean JK, Vivers S, Dransfield I, Godson C. Lipoxin A4 redistributes myosin iia and cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes. J. Immunol.176(3), 1878–1888 (2006).
   Google Scholar
• Olazabal IM, Caron E, May RC, Schilling K, Knecht DA, Machesky LM. Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcγR, phagocytosis. Curr. Biol.12(16), 1413–1418 (2002).
   PubMedGoogle Scholar
• Luo F. Simvastatin induces eosinophil apoptosis in vitro. Chest126(4), S721 (2004).
   Google Scholar
• Newton CJ, Ran G, Xie YX et al. Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone. J. Endocrinol.174(1), 7–16 (2002).
   PubMedGoogle Scholar
• Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JGN. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.288(6), L1026–L1032 (2005).
   PubMed Web of Science ®Google Scholar
• Chiba Y, Arima J, Sakai H, Misawa M. Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma. Am. J. Physiol. Lung Cell. Mol. Physiol.294(4), L705–L713 (2008).
   PubMed Web of Science ®Google Scholar
• McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol.172(5), 2903–2908 (2004).
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee DS, Kim EK et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am. J. Respir. Crit. Care Med.172(8), 987–993 (2005).
   PubMed Web of Science ®Google Scholar
• Mancini GBJ, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J. Am. Coll. Cardiol.47(12), 2554–2560 (2006).
   PubMed Web of Science ®Google Scholar
• Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur. Respir. J.29(2), 279–283 (2007).
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Keshamouni VG, Reddy RC. Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair. Proc. Am. Thorac. Soc.2(3), 226–231 (2005).
   PubMedGoogle Scholar
• Hammad H, de Heer HJ, Soullie T et al. Activation of peroxisome proliferator-activated receptor-γ in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am. J. Pathol.164(1), 263–271 (2004).
   PubMed Web of Science ®Google Scholar
• Liu D, Zeng BX, Zhang SH, Yao SL. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm. Res.54(11), 464–470 (2005).
   PubMed Web of Science ®Google Scholar
• Ward JE, Fernandes DJ, Taylor CC, Bonacci JV, Quan L, Stewart AG. The PPARγ ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation. Pulm. Pharmacol. Ther.19(1), 39–46 (2006).
   PubMed Web of Science ®Google Scholar
• Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol.28(12), 551–558 (2007).
   PubMed Web of Science ®Google Scholar
• Asada K, Sasaki S, Suda T, Chida K, Nakamura H. Antiinflammatory roles of peroxisome proliferator-activated receptor-g in human alveolar macrophages. Am. J. Respir. Crit. Care Med.169(2), 195–200 (2004).
   PubMed Web of Science ®Google Scholar
• Majai G, Sarang Z, Csomos K, Zahuczky G, Fesus L. PPARγ-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur. J. Immunol.37(5), 1343–1354 (2007).
   Google Scholar
• Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, Reynolds PN. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur. Respir. J.28(3), 486–495 (2006).
   PubMed Web of Science ®Google Scholar
• Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob. Agents Chemother.47(1), 48–53 (2003).
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Jersmann H et al. azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.178(2), 139–148 (2008).
   PubMed Web of Science ®Google Scholar
• Ren Y, Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol.154(5), 2366–2374 (1995).
   PubMed Web of Science ®Google Scholar
• Jinushi M, Nakazaki Y, Dougan M, Carrasco DR, Mihm M, Dranoff G. MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J. Clin. Invest.117(7), 1902–1913 (2007).
   PubMedGoogle Scholar
• Enzler T, Gillessen S, Manis JP et al. Deficiencies of GM-CSF and interferon-γ link inflammation and cancer. J. Exp. Med.197(9), 1213–1219 (2003).
   PubMed Web of Science ®Google Scholar
• Galati G, Rovere P, Citterio G et al.In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes. J. Leukoc. Biol.67(2), 174–182 (2000).
   PubMed Web of Science ®Google Scholar